The company, which sells eye implants, said Wednesday expects to report more than $90 million in the current quarter, compared to the $73 million analysts…
Peptides — a class of understudied and often injectable supplements — have boomed in popularity, with search interest for “peptides” surpassing “ozempic” this month.